Table 3.
Functional Outcomes of the Patients at the One Month Visit After Endopelvic Fascia Sparing Robotic Radical Cystectomy
| P | G | pT | pN | Qmax | Qave | Volume | PVR | DPU | NPU | Pre-op ED | Postop ED | T |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 4 | 0 | 36 | 12 | 260 | 10 | 0 | SP | NA | ||
| 2 | M | 1 | 0 | 7 | 0.8 | 100 | 0 | 0 | SP | No ED | No ED | |
| 3 | M | 0 | 0 | 19 | 4 | 250 | 0 | SP | SP | No ED | No ED | |
| 4 | M | IS | 0 | 7 | 0.7 | 350 | 0 | 0 | SP | Severe ED | Severe ED | |
| 5 | F | IS | 2 | 40 | 5.6 | 350 | 0 | 0 | SP | NA | ||
| 6 | M | 0 | 0 | 19 | 6.1 | 588 | 0 | 0 | 1 | No ED | Moderate ED | PDE5i |
| 7 | M | IS | 1 | 20 | 2.6 | 178 | 0 | 0 | SP | No ED | No ED | |
| 8 | M | 2 | 0 | 17 | 3.6 | 162 | 0 | SP | 1 | No ED | No ED | |
| 9 | M | 3 | 0 | 17 | 5 | 225 | 20 | SP | SP | No ED | No ED | |
| 10 | M | 0 | 0 | 18 | 7 | 350 | 0 | 0 | 1 | No ED | No ED | |
Abbreviations: P, patient; G; gender; pT, pathological tumor stage; pN, pathological nodal stage; Qmax, maximum urine flow rate; Qave, average urine flow rate; DPU, day pad use; NPU, night pad use; PVR, post-voided residual urine volume; SP, safety pad; ED, erectile dysfunction; T, treatment; F, female; M, male, IS, in situ; PDE5i, phosphodiesterase type 5 inhibitor.